Treating children with cancer is more costly than treating adolescents or adults, suggests a new study from The International Society for Pharmacoeconomics and Outcomes Research, or ISPOR.
Higher rates of hospitalization and higher hospitalization costs in children may explain some of the differences in costs between children and adolescents.
The report,
Costs for Childhood and Adolescent Cancer, 90 Days Pre-Diagnosis and 1-Year Post-Diagnosis: A Population-Based Study in Ontario, Canada, was published in the March 2017 issue of
Value in Health.
"This study is significant in that it included large, population-based cohorts of children and adolescents along with a comprehensive analysis of the vast majority of health care costs and all major cancer sites," noted co-authors Karen Bremner, Research Associate at the
Toronto General Hospital Research Institute, (TGHRI) and Dr. Claire de Oliveira, Centre of Addiction and Mental Health.
Dr. Murray Krahn, Senior Scientist at the TGHRI, is also a senior author of the study.
Read
Value in Health's
press release about this research here.
